Moyamoya and Inflammation

Area of Science:

• Neurology
• Immunology
• Epidemiology

Background:

• Moyamoya disease etiology remains unknown despite over 50 years since its initial description.
• While genetic and immunologic factors are implicated, they don’t fully explain moyamoya disease pathophysiology.
• A potential link between moyamoya disease and inflammatory conditions has been suggested but not extensively studied.

Purpose of the Study:

• To investigate the epidemiologic association between moyamoya disease and various inflammatory diseases.
• To analyze data from a large administrative database to explore these associations across different age groups.

Main Methods:

• Utilized the National Inpatient Sample database from 2009-2012.
• Identified moyamoya disease and inflammatory diseases using International Classification of Disease, 9th revision codes.
• Grouped patients into inflammatory disease clusters: atherosclerotic, adult-onset autoimmune, and juvenile-onset autoimmune diseases.

Main Results:

• A total of 2633 moyamoya disease admissions were analyzed.
• Moyamoya disease showed significant associations with atherosclerotic and juvenile-onset autoimmune diseases in both pediatric and adult patients.
• Adult-onset autoimmune disease was associated with moyamoya disease in pediatric patients but not in adults.

Conclusions:

• Moyamoya disease demonstrates associations with specific inflammatory disease clusters in both pediatric and adult populations.
• These findings highlight a potential pathophysiologic link between moyamoya disease and inflammatory processes.
• Further research is recommended to elucidate the mechanisms underlying the association between moyamoya disease and inflammatory conditions.